Western blot analysis revealed that BCL-2 expression was very heterogeneous in neuroblastoma cell lines, with some cell lines displaying relatively high BCL-2 protein levels (SJNB-12, Lan-5 and SMS-KCNR), and others having relatively low expression (SH-EP, CHP-212). This evidence concerns the gene BCL2 and neuroblastoma.